James (Jim) Neil Phillips Insider Profile
4 Followers
James (Jim) Neil Phillips, Chief Executive Officer at Biodexa Pharmaceuticals, holds 46.90K shares in Biodexa Pharmaceuticals (Ticker: BDRX), holds 46.90K shares in Midatech Pharma (Ticker: GB:BDRX).
James (Jim) Neil Phillips's Trading History
| BDRXBiodexa Pharmaceuticals | Dec 20, 2016 | Chief Executive Officer | Uninformative Sell | ― | $105.05K | |
| BDRXMidatech Pharma | ― | ― | ― | £1.76K |
You May Also Like
James (Jim) Neil Phillips insider profile FAQ
What is the percentage of profitable transactions made by James (Jim) Neil Phillips?
The percentage of profitable transactions made by James (Jim) Neil Phillips is 0%.
What is the average return per transaction made by James (Jim) Neil Phillips?
The average return per transaction made by James (Jim) Neil Phillips is -50.90%.
What stocks does James (Jim) Neil Phillips hold?
James (Jim) Neil Phillips holds: BDRX, GB:BDRX stocks.
What was James (Jim) Neil Phillips's most profitable transaction?
James (Jim) Neil Phillips’s most profitable transaction was an Informative Buy of BDRX stock on December 18, 2015. The return on the trade was -46.80%.
What is James (Jim) Neil Phillips's role in Biodexa Pharmaceuticals?
James (Jim) Neil Phillips's role in Biodexa Pharmaceuticals is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
